Feb 19 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- UK watchdog changes tack and provisionally approves $570 million travel deal
- AstraZeneca hit with US class action lawsuit over China regulatory probes
- UK Treasury rejects farmers' inheritance tax compromise
- Saudi Arabia's PIF seeks to evict Benko family from Innsbruck mansion
Overview
- The UK's competition watchdog has provisionally cleared a $570 million deal between U.S.-listed American Express Global Business Travel GBTG.N and rival CWT, in an unusual reversal of an earlier decision, as the regulator comes under government pressure to promote economic growth.
- AstraZeneca AZN.L has been hit with a U.S. class action lawsuit that claims the UK's largest listed company misled shareholders in connection with investigations by Chinese authorities.
- The UK Treasury has refused to entertain a compromise put forward by farming groups to soften the impact of UK inheritance tax reforms on the agricultural sector, despite growing pressure to reconsider the policy.
- Saudi Arabia's sovereign wealth fund has demanded the eviction of the family of bankrupt European property tycoon Rene Benko from their palatial home in Innsbruck, as it seeks to recover millions in losses from the collapse of the Signa Group.
(Compiled by Bengaluru newsroom)
((globalnewsmonitoring@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.